These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 14166196)
41. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS. JOHANSSON BW; NILSSON IM Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840 [No Abstract] [Full Text] [Related]
42. COAGULATION DISTURBANCES DURING EXTRACORPOREAL CIRCULATION AND THE POSTOPERATIVE PERIOD. BLOMBAECK M; NOREN I; SENNING A Acta Chir Scand; 1964 May; 127():433-45. PubMed ID: 14169772 [No Abstract] [Full Text] [Related]
43. [Parietal thromboplastin time, thromboplastin time fibrinogen, thrombin time and thrombocyte count in healthy and sick newborn infants]. Göbel U; Riech P Monatsschr Kinderheilkd (1902); 1972 Dec; 120(12):484-8. PubMed ID: 4646962 [No Abstract] [Full Text] [Related]
46. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube. d'Audigier C; Delassasseigne C; Robert A; Eschwège V Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495 [TBL] [Abstract][Full Text] [Related]
47. THE SEPARATION OF AUTOPROTHROMBIN I-C FROM BOVINE PROTHROMBIN PREPARATIONS. SEEGERS WH; KAGAMI M Can J Biochem; 1964 Sep; 42():1249-62. PubMed ID: 14217232 [No Abstract] [Full Text] [Related]
48. REQUIREMENT FOR CALCIUM IN THE THROMBOPLASTIN GENERATION TEST. GASTON LW; EVANGER AE J Lab Clin Med; 1964 Sep; 64():501-11. PubMed ID: 14215467 [No Abstract] [Full Text] [Related]
50. Activated prothrombin concentrate for patients with factor VIII inhibitors. Kurczynski EM; Penner JA N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485 [No Abstract] [Full Text] [Related]
51. INACTIVATION OF PATHOLOGICAL INHIBITORS OF INTRINSIC THROMBOPLASTIN BY PROCOAGULANT FROM HUMAN URINE. VONKAULLA KN; VONKAULLA E Acta Haematol; 1963 Jul; 30():25-34. PubMed ID: 14045901 [No Abstract] [Full Text] [Related]
52. The kaolin partial thromboplastin time as a screening test for coagulation disorders. Lurie A; Smith S S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371 [No Abstract] [Full Text] [Related]
53. Studies of the coagulation process in the crayfish, Orconectes virilis: attempts to identify a fibrinogen-like factor. Wood PJ; Karpawich PP Comp Biochem Physiol B; 1972 May; 42(1):41-8. PubMed ID: 5075770 [No Abstract] [Full Text] [Related]
54. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY. HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902 [No Abstract] [Full Text] [Related]
55. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Pineo GF; Regoeczi E; Hatton MW; Brain MC J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814 [No Abstract] [Full Text] [Related]
56. [CONSIDERATIONS ON COAGULATION IN LEPTOSPIROSIS OF RICE FIELD WORKERS]. MONTEVERDE A; GRAZIOLI C Folia Med (Napoli); 1963 Nov; 46():925-39. PubMed ID: 14159377 [No Abstract] [Full Text] [Related]
57. THROMBOPLASTIN FORMATION. POOL JG Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846 [No Abstract] [Full Text] [Related]
58. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. RATNOFF OD; CRUM JD J Lab Clin Med; 1964 Mar; 63():359-77. PubMed ID: 14165678 [No Abstract] [Full Text] [Related]
59. [STUDIES ON THE BLOOD COAGULATION SYSTEM IN PERSISTENT FORMS OF LYMPHATIC CIRCULATORY DISORDERS OF EXTREMITIES]. KOTOVISHCHIKOVA MA; MEDVEDEV PM Sov Med; 1963 Dec; 27():63-8. PubMed ID: 14150361 [No Abstract] [Full Text] [Related]